These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 7585504

  • 1. Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5' region of the c-akt proto-oncogene activated by long terminal repeat.
    Wada H, Matsuo M, Uenaka A, Shimbara N, Shimizu K, Nakayama E.
    Cancer Res; 1995 Nov 01; 55(21):4780-3. PubMed ID: 7585504
    [Abstract] [Full Text] [Related]

  • 2. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
    Tanino M, Matsuo M, Uenaka A, Tsukuda K, Ouchida M, Nakayama E, Shimizu K.
    Mol Carcinog; 1999 Dec 01; 26(4):286-97. PubMed ID: 10569805
    [Abstract] [Full Text] [Related]

  • 3. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M, Wada H, Honda S, Tawara I, Uenaka A, Kanematsu T, Nakayama E.
    J Immunol; 1999 Jun 01; 162(11):6420-5. PubMed ID: 10352255
    [Abstract] [Full Text] [Related]

  • 4. ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library.
    Uenaka A, Hata H, Win S, Ono T, Wada H, Nakayama E.
    Cancer Immun; 2001 Jul 13; 1():8. PubMed ID: 12747769
    [Abstract] [Full Text] [Related]

  • 5. Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications.
    Bellacosa A, Franke TF, Gonzalez-Portal ME, Datta K, Taguchi T, Gardner J, Cheng JQ, Testa JR, Tsichlis PN.
    Oncogene; 1993 Mar 13; 8(3):745-54. PubMed ID: 8437858
    [Abstract] [Full Text] [Related]

  • 6. [Analysis of tumor rejection antigen peptides recognized by specific CTL].
    Uenaka A, Nakayama E.
    Nihon Rinsho; 1996 Jan 13; 54(1):242-9. PubMed ID: 8587197
    [Abstract] [Full Text] [Related]

  • 7. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.
    Uenaka A, Ono T, Akisawa T, Wada H, Yasuda T, Nakayama E.
    J Exp Med; 1994 Nov 01; 180(5):1599-607. PubMed ID: 7964448
    [Abstract] [Full Text] [Related]

  • 8. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
    Ahmed NN, Franke TF, Bellacosa A, Datta K, Gonzalez-Portal ME, Taguchi T, Testa JR, Tsichlis PN.
    Oncogene; 1993 Jul 01; 8(7):1957-63. PubMed ID: 8510938
    [Abstract] [Full Text] [Related]

  • 9. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity.
    Faller DV, Weng H, Graves DT, Choi SY.
    J Cell Physiol; 1997 Aug 01; 172(2):240-52. PubMed ID: 9258345
    [Abstract] [Full Text] [Related]

  • 10. Molecular cloning and characterization of the gene encoding mouse melanoma antigen by cDNA library transfection.
    Hayashi H, Matsubara H, Yokota T, Kuwabara I, Kanno M, Koseki H, Isono K, Asano T, Taniguchi M.
    J Immunol; 1992 Aug 15; 149(4):1223-9. PubMed ID: 1380036
    [Abstract] [Full Text] [Related]

  • 11. Coordinate transcriptional control of murine endogenous retrovirus and Ig genes during B cell differentiation.
    Hummell DS, Dooley JS, Khan AS, Lawton AR.
    J Immunol; 1993 Sep 15; 151(6):3131-9. PubMed ID: 8397253
    [Abstract] [Full Text] [Related]

  • 12. The role of proximal and distal sequence variations in the presentation of an immunodominant CTL epitope encoded by the ecotropic AK7 MuLV.
    Kim V, Green WR.
    Virology; 1997 Sep 29; 236(2):221-33. PubMed ID: 9325230
    [Abstract] [Full Text] [Related]

  • 13. N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.
    Dolcetti R, Rizzo S, Viel A, Maestro R, De Re V, Feriotto G, Boiocchi M.
    Oncogene; 1989 Aug 29; 4(8):1009-14. PubMed ID: 2548143
    [Abstract] [Full Text] [Related]

  • 14. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M, Koller R, Haviernik P, Bies J, Maciag K, Wolff L.
    Oncogene; 2001 Sep 27; 20(43):6205-14. PubMed ID: 11593429
    [Abstract] [Full Text] [Related]

  • 15. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
    Harker WG, Slade DL, Parr RL, Holguin MH.
    Cancer Res; 1995 Nov 01; 55(21):4962-71. PubMed ID: 7585537
    [Abstract] [Full Text] [Related]

  • 16. Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
    Manki A, Ono T, Uenaka A, Seino Y, Nakayama E.
    Cancer Res; 1998 May 01; 58(9):1960-4. PubMed ID: 9581839
    [Abstract] [Full Text] [Related]

  • 17. Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts.
    Nagata Y, Furugen R, Hiasa A, Ikeda H, Ohta N, Furukawa K, Nakamura H, Furukawa K, Kanematsu T, Shiku H.
    J Immunol; 1997 Aug 01; 159(3):1336-43. PubMed ID: 9233630
    [Abstract] [Full Text] [Related]

  • 18. Frequent activation of the lck gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas.
    Shin S, Steffen DL.
    Oncogene; 1993 Jan 01; 8(1):141-9. PubMed ID: 8423992
    [Abstract] [Full Text] [Related]

  • 19. Deletion of c-myb exon 9 induced by insertion of repeats.
    Shinagawa T, Ishiguro N, Horiuchi M, Matsui T, Okada K, Shinagawa M.
    Oncogene; 1997 Jun 12; 14(23):2775-83. PubMed ID: 9190893
    [Abstract] [Full Text] [Related]

  • 20. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
    Tantravahi R, Dudek H, Patel G, Reddy EP.
    Oncogene; 1996 Sep 19; 13(6):1187-96. PubMed ID: 8808693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.